Adaptive Biotechnologies Corp Stock In The News
| ADPT Stock | USD 7.28 0.11 1.53% |
Our overall analysis of Adaptive Biotechnologies' news coverage and content from conventional and social sources shows investors' bearish mood towards Adaptive Biotechnologies Corp. The specific impact of Adaptive Biotechnologies news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Adaptive Biotechnologies' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Adaptive Biotechnologies headlines in addition to utilizing other, more conventional financial analysis modules. Check out Adaptive Biotechnologies Backtesting and Adaptive Biotechnologies Hype Analysis.
Adaptive |
Adaptive Biotechnologies Today Top News and Investor Outlook
Adaptive Biotechnologies Corp Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Adaptive and other traded companies coverage with news coverage. We help investors stay connected with Adaptive headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Adaptive Stock performance. Please note that trading solely based on the Adaptive Biotechnologies Corp hype is not for everyone as timely availability and quick action are needed to avoid losses.
Adaptive Biotechnologies stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Adaptive earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Adaptive Biotechnologies that are available to investors today. That information is available publicly through Adaptive media outlets and privately through word of mouth or via Adaptive internal channels. However, regardless of the origin, that massive amount of Adaptive data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Adaptive Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Adaptive Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Adaptive Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Adaptive Biotechnologies alpha.
Adaptive Largest EPS Surprises
Earnings surprises can significantly impact Adaptive Biotechnologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-02-26 | 2019-12-31 | -0.2 | -0.17 | 0.03 | 15 | ||
2021-02-24 | 2020-12-31 | -0.29 | -0.33 | -0.04 | 13 | ||
2020-05-12 | 2020-03-31 | -0.2 | -0.25 | -0.05 | 25 | ||
2022-11-03 | 2022-09-30 | -0.38 | -0.32 | 0.06 | 15 | ||
2022-08-03 | 2022-06-30 | -0.43 | -0.37 | 0.06 | 13 | ||
2024-11-07 | 2024-09-30 | -0.29 | -0.22 | 0.07 | 24 |
Adaptive Biotechnologies Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Adaptive Biotechnologies Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
12th of March 2025
Disposition of 53000 shares by Hershberg Robert of Adaptive Biotechnologies at 7.59 subjec... at MacroaxisInsider
10th of March 2025
Disposition of 50000 shares by Neupert Peter M of Adaptive Biotechnologies at 4.07 subject... at MacroaxisInsider
6th of March 2025
Disposition of 15664 shares by Griffin Michelle Renee of Adaptive Biotechnologies at 7.94 ... at MacroaxisInsider
5th of March 2025
Disposition of 36145 shares by Robins Chad M of Adaptive Biotechnologies at 6.99 subject t... at thelincolnianonline.com
20th of February 2025
Disposition of 99107 shares by Robins Chad M of Adaptive Biotechnologies at 6.32 subject t... at thelincolnianonline.com
18th of February 2025
Disposition of 211160 shares by Robins Chad M of Adaptive Biotechnologies at 6.32 subject ... at MacroaxisInsider
14th of February 2025
Disposition of 158921 shares by Robins Chad M of Adaptive Biotechnologies at 6.32 subject ... at gurufocus.com
13th of February 2025
Disposition of 100287 shares by Robins Chad M of Adaptive Biotechnologies at 6.32 subject ... at insidermonkey.com
12th of February 2025
Adaptive Biotechnologies Corp Q4 2024 Earnings Call Highlights Strong MRD Revenue ... at gurufocus.com
5th of February 2025
Adaptive Biotechnologies Corp Announces Participation in Key Investor Conferences at gurufocus.com
7th of January 2025
Adaptive Biotechnologies Corp Announces New Medicare Reimbursement Rate for clonoSEQ Test at gurufocus.com
Adaptive Biotechnologies Investors Sentiment
The influence of Adaptive Biotechnologies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Adaptive. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Adaptive Biotechnologies' public news can be used to forecast risks associated with an investment in Adaptive. The trend in average sentiment can be used to explain how an investor holding Adaptive can time the market purely based on public headlines and social activities around Adaptive Biotechnologies Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Adaptive Biotechnologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Adaptive Biotechnologies' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Adaptive Biotechnologies' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Adaptive Biotechnologies.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adaptive Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adaptive Biotechnologies' short interest history, or implied volatility extrapolated from Adaptive Biotechnologies options trading.
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.